What is the anticipated management for a patient diagnosed with preeclampsia without severe features at 35 3/7 weeks' gestation?

For a patient diagnosed with preeclampsia without severe features at 35 3/7 weeks' gestation, the anticipated management typically involves expectant management until induction at 37 weeks' gestation. This approach is crucial in order to balance the risks associated with both preeclampsia and premature delivery.

At this gestational age, careful monitoring is essential, as preeclampsia can lead to complications for both the mother and the fetus if it progresses. However, when severe features are absent, the risks of immediate induction before 37 weeks may outweigh the benefits. Allowing the pregnancy to continue until 37 weeks enables the fetus to mature further, reducing the likelihood of complications associated with prematurity, such as respiratory distress syndrome.

Expectant management involves regular assessments of the mother and fetus, including monitoring blood pressure, urine protein, and fetal wellbeing, to ensure that the condition does not worsen before the planned delivery at 37 weeks. This conservative approach helps ensure the best possible outcomes for both the mother and baby while still providing timely intervention when necessary.